Oyster Point Pharma, Inc.

OYSTDelisted Jan 3, 2023

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001720725

SEC filings (opens in a new tab)

Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.

Superinvestors holding OYST, Q4 2022

See all superinvestors

No superinvestor reported holding OYST in Q4 2022.